4//SEC Filing
GREENLEAF DANIEL E 4
Accession 0001127602-19-019235
CIK 0001014739other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 8:12 PM ET
Size
8.8 KB
Accession
0001127602-19-019235
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
GREENLEAF DANIEL E
Chief Executive Officer
Transactions
- Disposition to Issuer
Common Stock, $.0001 Par Value
2019-05-16$2.00/sh−62,734$125,468→ 375,305 total - Exercise/Conversion
Restricted Stock Unit
2019-05-16−197,727→ 0 total→ Common Stock, $.0001 Par Value (197,727 underlying) - Exercise/Conversion
Common Stock, $.0001 Par Value
2019-05-16+197,727→ 438,039 total
Footnotes (4)
- [F1]197,727 Restricted Stock Units (RSUs) vested on the first anniversary of the original grant date (May 3, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 197,727 RSUs until May 16, 2019.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
- [F3]This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the RSU award described in this Form 4 that was settled on May 16, 2019.
- [F4]The Restricted Stock Units vest on the first anniversary of the date of grant.
Documents
Issuer
BioScrip, Inc.
CIK 0001014739
Entity typeother
Related Parties
1- filerCIK 0001208492
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 8:12 PM ET
- Size
- 8.8 KB